Get the Stockscreener App
2.33
5.43%
0.12
After Hours:
2.33
Goodrx Holdings Inc stock is traded at $2.33, with a volume of 2.69M.
It is up +5.43% in the last 24 hours and down -16.79% over the past month.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
See More
Previous Close:
$2.21
Open:
$2.22
24h Volume:
2.69M
Relative Volume:
1.05
Market Cap:
$790.88M
Revenue:
$775.09M
Net Income/Loss:
$-58.68M
P/E Ratio:
-17.57
EPS:
-0.1326
Net Cash Flow:
$64.06M
1W Performance:
+7.87%
1M Performance:
-16.79%
6M Performance:
-32.85%
1Y Performance:
-53.02%
1-Day Range:
$2.22
$2.43
1-Week Range:
$2.115
$2.685
52-Week Range:
$2.10
$5.8099
Goodrx Holdings Inc Stock (GDRX) Company Profile
Name
Goodrx Holdings Inc
Sector
Industry
Phone
(855) 268-2822
Address
2701 OLYMPIC BOULEVARD, SANTA MONICA
Compare GDRX vs VEEV, TEM, BTSG, HQY, DOCS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GDRX
Goodrx Holdings Inc
|
2.33 | 750.15M | 775.09M | -58.68M | 64.06M | -0.1326 |
|
VEEV
Veeva Systems Inc
|
186.99 | 30.35B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
55.88 | 10.16B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
39.34 | 7.17B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
78.35 | 6.77B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
27.24 | 5.08B | 550.17M | 201.35M | 232.07M | 1.00 |
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-22-26 | Downgrade | Jefferies | Buy → Hold |
| Dec-09-25 | Initiated | Barclays | Underweight |
| Aug-11-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Aug-09-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| May-23-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| May-16-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-10-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-01-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-02-24 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-10-23 | Upgrade | DA Davidson | Neutral → Buy |
| Jul-31-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Dec-01-22 | Initiated | Citigroup | Buy |
| Nov-04-22 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-12-22 | Initiated | DA Davidson | Neutral |
| Jun-10-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-06-22 | Resumed | BofA Securities | Buy |
| Jun-01-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-10-22 | Downgrade | Evercore ISI | Outperform → In-line |
| May-10-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-10-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-10-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-11-22 | Initiated | Wells Fargo | Equal Weight |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Neutral |
| Mar-15-22 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-01-22 | Reiterated | Barclays | Overweight |
| Mar-01-22 | Reiterated | BofA Securities | Neutral |
| Mar-01-22 | Downgrade | Cowen | Outperform → Market Perform |
| Mar-01-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Mar-01-22 | Reiterated | Evercore ISI | Outperform |
| Mar-01-22 | Reiterated | Goldman | Buy |
| Mar-01-22 | Reiterated | JP Morgan | Underweight |
| Mar-01-22 | Reiterated | RBC Capital Mkts | Outperform |
| Mar-01-22 | Reiterated | SVB Leerink | Outperform |
| Jan-07-22 | Initiated | Goldman | Buy |
| Dec-21-21 | Initiated | Stephens | Overweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Aug-31-21 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-13-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-06-21 | Resumed | Evercore ISI | Outperform |
| Jan-25-21 | Initiated | Guggenheim | Buy |
| Nov-19-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-18-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-19-20 | Initiated | Barclays | Equal Weight |
| Oct-19-20 | Initiated | BofA Securities | Neutral |
| Oct-19-20 | Initiated | Citigroup | Buy |
| Oct-19-20 | Initiated | Cowen | Outperform |
| Oct-19-20 | Initiated | Credit Suisse | Outperform |
| Oct-19-20 | Initiated | Deutsche Bank | Hold |
| Oct-19-20 | Initiated | Goldman | Neutral |
| Oct-19-20 | Initiated | JP Morgan | Neutral |
| Oct-19-20 | Initiated | Morgan Stanley | Overweight |
| Oct-19-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-19-20 | Initiated | SVB Leerink | Outperform |
| Oct-19-20 | Initiated | UBS | Buy |
View All
Goodrx Holdings Inc Stock (GDRX) Latest News
How Recent Analyst Shifts Are Rewriting The Story For GoodRx Holdings (GDRX) - Yahoo Finance
GoodRx (GDRX) Lifts Guidance as Pharma Partnerships Drive Double-Digit Growth - MSN
Is GoodRx (GDRX) Using ARAKODA Discounts To Quietly Redefine Its Preventive Care Strategy? - Yahoo Finance
GoodRx Holdings, Inc.'s (NASDAQ:GDRX) biggest owners are retail investors who got richer after stock soared 7.5% last week - simplywall.st
GoodRx (GDRX) Partners with Pfizer for Discounts on TrumpRx - GuruFocus
Headwinds in GoodRx’s (GDRX) Drug Prescription Business Draw Cautious View from Jefferies - Insider Monkey
GoodRx becomes pricing source for Pfizer and other drugmakers on TrumpRx - Seeking Alpha
11 Best Stocks Under $3 to Buy Right Now - Insider Monkey
Amazon Is Now Offering Novo Nordisk's Wegovy Pill in Its Pharmacy. Here's How That Could Affect Hims & Hers, WW International, and GoodRx Holdings. - Yahoo Finance
Amazon Is Now Offering Novo Nordisk's Wegovy Pill in Its Pharmacy. Here's How That Could Affect Hims & Hers, WW International, and GoodRx Holdings. - The Motley Fool
GoodRx powers pricing for leading Brand Medications on TrumpRX - marketscreener.com
Pfizer cuts prices up to 85% on 30+ drugs via TrumpRx and GoodRx - Stock Titan
GoodRx stock climbs amid TrumpRx launch speculation By Investing.com - Investing.com Canada
GoodRx (GDRX) to Offer Savings on Arakoda in New Partnership - GuruFocus
GoodRx system that saved Americans $100B earns key data safety seal - Stock Titan
Risk Report: Can GoodRx Holdings Inc expand its profit marginsQuarterly Profit Report & Accurate Buy Signal Alerts - baoquankhu1.vn
Published on: 2026-01-30 09:08:15 - baoquankhu1.vn
GoodRx Announces Date for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call - Caledonian Record
GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring An 80% Upside Potential - DirectorsTalk Interviews
Is GoodRx Holdings Inc. showing insider buyingWeekly Investment Summary & Long-Term Safe Investment Ideas - mfd.ru
Q3 Earnings Highlights: GoodRx (NASDAQ:GDRX) Vs The Rest Of The Healthcare Technology Stocks - Finviz
Rate Hike: How does GoodRx Holdings Inc perform in inflationary periodsPortfolio Value Report & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Demystifying GoodRx Holdings: Insights From 8 Analyst Reviews - Benzinga
Weekly Recap: What is HBANLs revenue forecastGlobal Markets & Daily Profit Focused Stock Screening - baoquankhu1.vn
Activity Recap: Can GoodRx Holdings Inc deliver consistent EPS growthJuly 2025 Snapshot & Fast Gain Stock Trading Tips - baoquankhu1.vn
GDRX: Jefferies Downgrades GoodRx Holdings with Significant PT R - GuruFocus
Leerink Partners Remains Bullish on GoodRx Holdings (GDRX) - MSN
Jefferies downgrades GoodRx stock to Hold on prescription segment challenges - Investing.com Nigeria
Jefferies Downgrades GoodRx Holdings Inc. (GDRX) to Hold - StreetInsider
GoodRx Users Denied Nod For $32M Deal In Data Sharing Row - Law360
Valuation Update: Whats the MACD signal for GoodRx Holdings Inc2025 Market Overview & Smart Swing Trading Alerts - baoquankhu1.vn
GoodRx’s $32 Million Info-Sharing Deal Fails to Get Court Nod - Bloomberg Law News
GoodRx Holdings, Inc.'s (NASDAQ:GDRX) last week's 6.9% decline must have disappointed individual investors who have a significant stake - Yahoo Finance
GoodRx Holdings, Inc. (NASDAQ:GDRX) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? - simplywall.st
GoodRx won't be participating with TrumpRx: report - MSN
GoodRx (NASDAQ:GDRX) Upgraded at Wall Street Zen - MarketBeat
Aug Swings: What is the next catalyst for GoodRx Holdings IncJuly 2025 Drop Watch & Daily Price Action Insights - baoquankhu1.vn
Recap Report: What is the next catalyst for GoodRx Holdings IncBreakout Watch & Community Consensus Trade Alerts - baoquankhu1.vn
GoodRx CEO on TrumpRx and Surescripts Partnership - marketscreener.com
Performance Recap: Will GoodRx Holdings Inc stock deliver shareholder valueJuly 2025 Update & Consistent Return Investment Signals - Bộ Nội Vụ
Drug price tool shows pharmacy costs upfront with GoodRx savings - Stock Titan
BofA maintains underperform rating on GoodRx (GDRX) while trimming PT to $2.60 - MSN
BofA Maintains Underperform Rating on GoodRx (GDRX) While Trimming PT to $2.60 - Finviz
Citigroup Maintains Buy Rating on GoodRx (GDRX) but Lowers Price Target | GDRX Stock News - GuruFocus
Citigroup Has Lowered Expectations for GoodRx (NASDAQ:GDRX) Stock Price - MarketBeat
GoodRx Holdings (FRA:8GH) 3-Year RORE % : 57.89% (As of Sep. 2025) - GuruFocus
GoodRx Holdings (FRA:8GH) Days Inventory : 0.00 (As of Sep. 2025) - GuruFocus
Enterprise value to EBITDA ratio of GoodRx Holdings, Inc. Class A – FWB:8GH - TradingView — Track All Markets
GoodRx Holdings (FRA:8GH) EPS (Basic) : €0.09 (TTM As of Sep. 2025) - GuruFocus
GoodRx Holdings (FRA:8GH) Common Stock : €0.0 Mil (As of Sep. 2025) - GuruFocus
GoodRx Holdings (FRA:8GH) EV-to-Revenue : 1.30 (As of Jan. 09, 2026) - GuruFocus
Goodrx Holdings Inc Stock (GDRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
6.79%
3.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):